Liz Szabo
From this contributor
How anti-vaccine activists are using COVID-19 to boost their movement
While most of the world hungers for a vaccine to put an end to the death and economic destruction wrought by COVID-19, some anti-vaccine groups are joining anti-lockdown protesters to challenge restrictions aimed at protecting public health.
How anti-vaccine activists are using COVID-19 to boost their movement
Landmark mental health bill sails through U.S. Senate
The 21st Century Cures Act, having passed the U.S. Senate, now goes to President Barack Obama, who has promised to sign it.
Landmark mental health bill sails through U.S. Senate
Massive mental health bill faces vote in U.S. Congress
If passed, the $6.3 billion 21st Century Cures Act would make mental health a national priority.
Massive mental health bill faces vote in U.S. Congress
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.